Pension Fund for Pharmacists

Pension Fund for Pharmacists

Founded in 1925 as the Bavarian Pharmacists' Pension Scheme (Bayerische Apothekerversorgung, or BAPV), the fund is a public-law institution providing old-age, disability, and survivor benefits to pharmacy professionals across Germany. It operates as one of twelve professional pension schemes administered by BVK, the Munich-based public pension management group. BAPV expanded into a full pension scheme by the 1960s and today serves over 40,000 members and pension recipients, pooling mandatory contributions from Bavarian pharmacists into a diversified long-term portfolio. The fund pursues a multi-asset strategy centered on direct real estate, infrastructure, and timber with additional allocations to private equity. Its real estate book includes trophy office properties co-owned with partners: the Transamerica Pyramid in San Francisco, the Gucci-anchored 685 Fifth Avenue in Manhattan (a joint venture with Michael Shvo), and the Cordusio building in Milan. In Germany, BAPV holds positions in EDGE East Side Berlin, Designer Outlets Wolfsburg, and BVK's own Munich headquarters. The global timber portfolio and infrastructure holdings span multiple continents, while the fund maintains investor memberships in INREV and GRESB for real-asset benchmarking. BAPV's assets are managed within BVK's consolidated framework, which historically operated with a lean internal team and a network of external mandates. The fund is a signatory to the UN Principles for Responsible Investment since 2011, a Net-Zero Asset Owner Alliance member since 2021, and reports through GRESB. Philanthropically, it supports the Stiftung Tanz – Transition Zentrum Deutschland, a dance-focused foundation. No recent strategic pivot or leadership change is publicly documented; the fund continues its steady-state accumulation and benefit-payment cycle. Structurally, BAPV differs from peer German pension schemes by the depth of its direct real-asset exposure — owning landmark buildings directly rather than through blind-pool funds. Its administration by BVK gives it access to a pooled investment platform typically reserved for larger institutional mandates, while remaining legally ring-fenced for Bavarian pharmacists. Succession and governance remain tied to BVK's supervisory board structure, with no publicly disclosed plans for independent management.